Trump Nominates Hahn As New FDA Commish; Acting Head Sharpless Returns To NCI

The White House has announced President Trump’s intent to nominate MD Anderson’s Stephen Hahn as the next FDA commissioner. The position has been held by acting commissioner Ned Sharpless for the past seven months. Admiral Brett Giroir will helm the agency on an acting basis until the new commissioner is confirmed.

Stephen Hahn of MD Anderson Cancer Center is expected to be nominated for FDA commissioner
Stephen Hahn

More from Regulation

More from Policy & Regulation